CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
50.48
0.00 (0.00%)
Nov 13, 2026, 12:58 PM EST - Market open
CONMED Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,369 | 1,375 | 1,307 | 1,245 | 1,045 | 1,011 | |
Revenue Growth | 1.62% | 5.18% | 5.00% | 19.06% | 3.45% | 17.18% |
Cost of Revenue | 619.05 | 634.15 | 573.98 | 568.5 | 469.73 | 442.6 |
Gross Profit | 750.24 | 740.58 | 733.03 | 676.25 | 575.75 | 568.04 |
Selling, General & Admin | 547.67 | 556.12 | 519.33 | 505.46 | 441.42 | 414.73 |
Research & Development | 62.32 | 55.88 | 54.43 | 52.6 | 47.15 | 43.57 |
Operating Expenses | 609.99 | 612 | 573.75 | 558.06 | 488.57 | 458.29 |
Operating Income | 140.25 | 128.57 | 159.28 | 118.18 | 87.17 | 109.74 |
Interest Expense | -36.95 | -31.09 | -37.3 | -39.78 | -28.91 | -35.49 |
Other Non Operating Income (Expenses) | -1.78 | -0.42 | - | - | - | -0.05 |
EBT Excluding Unusual Items | 101.53 | 97.07 | 121.98 | 78.41 | 58.27 | 74.21 |
Merger & Restructuring Charges | -2.4 | -12.9 | - | - | -14.6 | - |
Other Unusual Items | 5.84 | -13.05 | 41.05 | 2.42 | -114.53 | -1.1 |
Pretax Income | 104.96 | 71.12 | 163.03 | 80.83 | -70.86 | 73.11 |
Income Tax Expense | 31.53 | 24.06 | 30.61 | 16.37 | 9.72 | 10.56 |
Net Income | 73.43 | 47.06 | 132.42 | 64.46 | -80.58 | 62.54 |
Net Income to Common | 73.43 | 47.06 | 132.42 | 64.46 | -80.58 | 62.54 |
Net Income Growth | 14.61% | -64.47% | 105.44% | - | - | 557.16% |
Shares Outstanding (Basic) | 30 | 31 | 31 | 31 | 30 | 29 |
Shares Outstanding (Diluted) | 30 | 31 | 31 | 32 | 30 | 32 |
Shares Change | -2.14% | -0.00% | -1.26% | 5.02% | -6.75% | 9.34% |
EPS (Basic) | 2.42 | 1.52 | 4.29 | 2.10 | -2.68 | 2.14 |
EPS (Diluted) | 2.41 | 1.51 | 4.25 | 2.04 | -2.68 | 1.94 |
EPS Growth | 17.46% | -64.47% | 108.33% | - | - | 506.25% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 132.69 | 150.88 | 153.88 | 106.32 | 11.58 | 96.9 |
Free Cash Flow Per Share | 4.35 | 4.84 | 4.94 | 3.37 | 0.39 | 3.01 |
Dividend Per Share | - | 0.600 | 0.800 | 0.800 | 0.800 | 0.800 |
Dividend Growth | - | -25.00% | 0% | 0% | 0% | 0% |
Gross Margin | 54.79% | 53.87% | 56.08% | 54.33% | 55.07% | 56.21% |
Operating Margin | 10.24% | 9.35% | 12.19% | 9.49% | 8.34% | 10.86% |
Profit Margin | 5.36% | 3.42% | 10.13% | 5.18% | -7.71% | 6.19% |
Free Cash Flow Margin | 9.69% | 10.98% | 11.77% | 8.54% | 1.11% | 9.59% |
EBITDA | 214.97 | 201.65 | 229.74 | 188.36 | 154.59 | 177.19 |
EBITDA Margin | 15.70% | 14.67% | 17.58% | 15.13% | 14.79% | 17.53% |
D&A For EBITDA | 74.72 | 73.08 | 70.46 | 70.17 | 67.42 | 67.44 |
EBIT | 140.25 | 128.57 | 159.28 | 118.18 | 87.17 | 109.74 |
EBIT Margin | 10.24% | 9.35% | 12.19% | 9.49% | 8.34% | 10.86% |
Effective Tax Rate | 30.04% | 33.83% | 18.77% | 20.25% | - | 14.45% |